Zdrowie i gospodarka · 23/01/2017

FDA Withdraws ACTHAR GEL SYNTHETIC Injection Due to Safety or Effectiveness Concerns

The US Food and Drug Administration (FDA) has withdrawn ACTHAR GEL SYNTHETIC (seractide acetate) injection, 80 units/mL and 40 units/mL from sale due to safety or effectiveness concerns. The FDA will not review abbreviated new drug applications (ANDAs) for these products.